Amyloidosis is a classic disorder of protein metabolism characterized by the extracellular deposition of abnormal protein complexes (glycoproteins and polysaccharides) in tissues and vessel walls. This pathology significantly impairs organ and tissue function, frequently resulting in fatal outcomes.
Core ProcessDeposition of glycoproteins in vessels and tissues
Main FormsHereditary, acquired, and idiopathic
Renal Clinical FindingsAlbuminuria, hyperazotemia, and uremia
Blood PressureArterial hypotension due to hypovolemia
Pathology Classification
In modern medical practice, metabolic disorders of this group are classified based on their etiology and pathogenesis. The main variants include:
Hereditary variant (primary).
Acquired variant (secondary).
Idiopathic variant.
Clinical Manifestations
The pathological process causes severe disruptions in body systems. Key symptoms include:
Albuminuria — caused by impaired renal tubular reabsorption of albumins.
Hypoproteinemia — develops secondary to renal dysfunction and urinary loss of albumins.
Arterial hypotension — provoked by adrenal insufficiency and a decrease in circulating blood volume.
Hyperazotemia and uremia — develop against the background of progressive renal failure.
Comparison with Hyalinosis
It is important to differentiate this condition from other metabolic disorders. For instance, hyalinosis represents a different classic form of protein pathology characterized by the deposition of non-amyloid proteins within connective tissue structures.
Mnemonic
"A-H-H-U": Albuminuria, Hypoproteinemia, Hypotension, Uremia — the main cardiorenal markers of amyloidosis.
Frequently asked questions
What is the detailed pathogenesis of albuminuria in amyloidosis?
Albuminuria in amyloidosis develops as a result of impaired albumin reabsorption in the kidneys. The deposition of abnormal protein complexes in the renal glomeruli (in the mesangium, subendothelial space, and subepithelial space) impairs their filtration function. These progressive filtration and reabsorption disorders lead to heavy proteinuria, subsequently causing classic nephrotic syndrome.
What biochemical types of fibrillar protein (amyloid) are distinguished in modern classification?
The modern classification distinguishes the following main biochemical types of amyloid based on the precursor protein:
AL amyloid — derived from immunoglobulin light chains (Bence-Jones protein), characteristic of primary amyloidosis.
AA amyloid — derived from serum amyloid A (SAA) protein, characteristic of secondary reactive amyloidosis.
ATTR amyloid — derived from normal or mutant transthyretin, seen in hereditary and senile systemic amyloidosis.
What are the clinical stages in the course of renal amyloidosis?
The course of renal amyloidosis includes four sequential clinical stages reflecting the pathomorphological progression from asymptomatic deposition to glomerular destruction:
Latent — the initial stage.
Proteinuric — characterized by protein loss.
Nephrotic — accompanied by the development of classic nephrotic syndrome.
Azotemic — the terminal stage, characterized by chronic renal failure and uremia.
What specific histochemical stains are used to identify amyloid in tissues?
To identify amyloid in tissues, histochemical staining with Congo red is used. Under light microscopy, amyloid stains brick-red (orange-red). Under subsequent polarized light microscopy, the stained preparation exhibits dichroism (birefringence) and displays a characteristic apple-green birefringence. This is a pathognomonic feature that allows differentiation of amyloid from collagen and fibrin.
What is amyloidosis from a pathophysiological standpoint?
It is a standard pathology of protein metabolism characterized by the excessive deposition of glycoproteins in the extracellular matrix and vascular walls.
What are the primary causes leading to the development of this pathology?
Frequent causes include chronic inflammatory conditions, autoimmune diseases, as well as tissue infiltration by plasma proteins in diabetes mellitus, arteriosclerosis, and hypertension.
Why does hypoproteinemia develop in this disease?
Hypoproteinemia is a direct consequence of renal failure and marked albuminuria, through which the body loses essential proteins.
Go deeper
Mechanisms of impaired albumin reabsorption in the kidneys
Pathogenesis of adrenal insufficiency in hypotension
Differences between primary and secondary variants of the pathology
The role of autoimmune processes in the accumulation of abnormal complexes
Pathogenetic link between hyperazotemia and uremia